Immunic Inc (IMUX)
Warby Parker Inc (WRBY)
New Form 8-K - Warby Parker Inc. Filed: 2025-08-07 AccNo: 0001504776-25-000024 Size: 456 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Warby Parker Inc (WRBY)
Warby Parker - Warby Parker Announces Second Quarter 2025 Results
Warby Parker Inc (WRBY)
Warby Parker Announces Second Quarter 2025 Results
Eli Lilly and Company (LLY)
Lilly reports second-quarter 2025 financial results and raises guidance
Nuvalent Inc (NUVL)
Immunic Inc (IMUX)
Becton Dickinson and Company (BDX)
Nuvalent Inc (NUVL)
Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results
Prenetics Global Ltd (PRE)
Zimmer Biomet Holdings Inc (ZBH)
Zimmer Biomet Holdings, Inc. Notification